![]() |
|
|
Molecular Pharmacology, Vol 16, 909-921, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine,
Baltimore, Maryland 21201
The effects of the local anesthetic piperocaine were investigated on the endplate current
(EPC) of frog sartorius muscles and on the binding of ligands to the acetylcholine (ACh)
receptor and its ion channel in membranes from the electric organ of Torpedo ocellata.
Piperocaine (10-100 µM) did not prevent action potential activity in nerve or muscle.
However, these concentrations of piperocaine depressed reversibly the peak amplitude of
EPCs in a dose-dependent manner without altering the EPC reversal potential. The
current-voltage relationship obtained with short conditioning voltage durations preceding
the EPC remained approximately linear at the piperocaine concentrations used. When
the time during which the membrane potential was maintained preceding the EPC was
lengthened from 10 to 500 msec in presence of piperocaine, the current-voltage relationship became markedly nonlinear, thus suggesting that there was more binding of the drug
to the ACh-receptor ion channel complex. Both drug concentration and increasingly
negative membrane potential augmented this time-dependent effect. At negative membrane potentials piperocaine also reversibly accelerated the rise and decay times of the
EPC, while the EPC falling phase remained a single exponential function of time. The
relationship between log of EPC decay time constant (
) and membrane potential was
linear in presence of piperocaine, and the slope progressively decreased and reversed its
direction as piperocaine concentration was increased, with the maximum observed acceleration of
being at 75 µM of drug. The effect of piperocaine on
was voltage dependent
but time independent. Piperocaine inhibited competitively [3H]perhydrohistrionicotoxin
binding to the electric organ membranes, with an inhibition constant (Ki) of 0.44 µM; and
noncompetitively [3H]ACh binding to its ACh-receptor with a Ki of 12.0 µM. These
findings suggest that piperocaine has at least two separate actions at the ACh-receptorion channel complex. One is binding to open channels which causes concentration and
voltage-dependent alteration of EPC time course and decreased EPC amplitude and
voltage sensitivity of the EPC falling phase. Another is binding to a less well-defined site
on the ACh receptor ion channel complex, an action that leads to a further depression of
the peak amplitude of the EPC which is concentration, voltage and also time-dependent.
Note:
ACKNOWLEDGMENT
We are grateful to Drs. B. Witkop and J. Daly of
NIH for supplying us with the [3H]H12-HTX used in
the present study. We are most indebted to Ms. Mabel
A. Zelle for all the computer analysis.